Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
48.6%
% of BHCHX's 40 holdings also in IXJ
16.1%
% of IXJ's 112 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BHCHX |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY AND COMPANY | 9.3% | 8.2% | 8.2% |
|
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 7.6% | 7.3% |
|
MERCK & CO., INC. | 4.8% | 3.4% | 3.4% |
|
THERMO FISHER SCIENTIFIC INC | 4.7% | 2.7% | 2.7% |
|
INTUITIVE SURGICAL, INC. | 5.8% | 2.6% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to IXJ
 |
ARGENX SE ADR | 4.1% |
|
BOSTON SCIENTIFIC CORPORATION | 3.5% |
|
BOSTON SCIENTIFIC CORP | 3.5% |
 |
ICON PLC | 3.2% |
|
INTUITIVE SURGICAL, INC. | 3.2% |
|
INTUITIVE SURGICAL INC | 3.2% |
|
VERTEX PHARMACEUTICALS INCORPORATED | 2.9% |
|
VERTEX PHARMACEUTICALS INC | 2.9% |
|
ARCELLX, INC. | 2.6% |
|
THE COOPER COMPANIES, INC. | 2.3% |
BHCHX Underweight Relative to IXJ
|
JOHNSON & JOHNSON | -4.9% |
 |
NOVO NORDISK A/S-B | -4.4% |
|
ABBVIE INC | -4.1% |
 |
NOVARTIS AG | -2.8% |
|
ROCHE HOLDING LTD | -2.8% |
|
ABBOTT LABORATORIES | -2.8% |
 |
ASTRAZENECA PLC | -2.7% |
|
AMGEN INC | -2.1% |
|
PFIZER INC | -2.0% |
|
BRISTOL-MYERS SQUIBB CO | -1.6% |